Skip to main content
Caplight Logo









GENICON, Inc.

GENICON, Inc.

Private
Winter Park, FloridaHealthcare & Life Scienceshttps://geniconendo.com

Last Round

Debt

Jul 20, 2017

Total Funding Raised

$12.6M

Company Overview

GENICON, Inc. operates in Healthcare & Life Sciences and is based in Winter Park, Florida. Its latest recorded funding round was a Debt round in July 2017.

GENICON, Inc. is a medical device company that designs, produces, and distributes patented surgical instrumentation focused on the laparoscopic surgery market.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

GENICON, Inc. Comparables

Compare GENICON, Inc. with similar companies based on industry and business-model similarity.

GENICON, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ackermann Instrumente GmbH
88%
Applied Medical
86%
Purple Surgical
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

GENICON, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJul 20, 2017
DebtApr 21, 2016
Series BApr 20, 2015
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

GENICON, Inc. Investors

Notable investors and investment history

GENICON, Inc. investors
InvestorRounds
Advantage CapitalDebt, Series B
Coastal Enterprises, Inc.Debt
Rand Capital BDCDebt, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2016

    $2M round led by Rand Capital BDC

Book a demo to see all signals

For institutional investors. Book with your work email.

GENICON, Inc. Filings

Explore SEC and related filing metadata, where available.

GENICON, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about GENICON, Inc.'s valuation, stock price, and market status.

Is GENICON, Inc. a public or private company?

GENICON, Inc. is a private company.

What is the current stock price of GENICON, Inc.?

GENICON, Inc. is a private company, so its shares have no public market price. Caplight tracks GENICON, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is GENICON, Inc. worth (valuation)?

Valuation information for GENICON, Inc. is not publicly available.

Can I buy GENICON, Inc. stock?

GENICON, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was GENICON, Inc.'s last funding round?

GENICON, Inc.'s most recent funding round was Debt on July 20, 2017.

Who are the main investors in GENICON, Inc.?

Key investors in GENICON, Inc. include Advantage Capital, Rand Capital BDC.

Will GENICON, Inc. IPO soon?

No public IPO plans have been announced for GENICON, Inc..

How can I track GENICON, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in GENICON, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersWinter Park, Florida
Employee Range10
Year Founded1998
Last FundingJul 20, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?